Along with cholesterol, triglycerides
are a type of lipid, or blood fat.
This trial, focusing specifically on high triglyceride
patients with diabetes, will definitively test whether triglyceride
reduction can reduce cardiac events" said Paul Ridker, MD, director of the Center for Cardiovascular Disease Prevention at BWH and co-PI of the planned trial.
Variable NN group Fasting triglycerides
(mg/dl) 100.11 [+ or -] 21.04 Postprandial triglycerides
(mg/dl) 152.52 [+ or -] 31.15 CIMT (mm) 0.93 [+ or -] 0.32 Variable NH group Fasting triglycerides
(mg/dl) 116.0 [+ or -] 20.8 Postprandial triglycerides
(mg/dl) 274.26 [+ or -] 54.33 CIMT (mm) 1.48 [+ or -] 0.54 Variable HH group Fasting triglycerides
(mg/dl) 197.28 [+ or -] 65.76 P<0.01 Postprandial triglycerides
(mg/dl) 296.92 [+ or -] 65.76 P<0.01 CIMT (mm) 1.79 [+ or -] 0.45 P<0.01 1.
Those studies, published in The New England Journal of Medicine and funded by the National Institutes of Health and the European Union, provide "a very, very strong type of evidence,'' Hegele said, that triglycerides
are in fact a cause of heart attacks.
Reduced intake of sugar-sweetened beverages and of high glycemic index foods will lower serum triglycerides
. Exercise and weight loss are also important components of triglyceride
And we sometimes call triglycerides
a barometer of metabolic health because high triglycerides
are a sign of a disturbed metabolism.
Normal non-fasting triglyceride
levels -- revealed by blood tests associated with regular physical exams -- are generally considered to be somewhere between 35 mg/dL and 150 to 199 mg/dL.
"From our review of the evidence from 17 randomized, controlledA clinical trials on high triglyceride
levels, we concluded that treatment with 4 grams daily of any of the available prescription [omega-3A medications ] is effective and can be used safely in conjunction withA statin A medicines thatA lower cholesterol," Ann Skulas-Ray, one of the study's authors, said, which was published in the journal Circulation.
[USA], Aug 19 (ANI): Omega-3 fatty acid medication reduces triglyceride
levels by 20-30 per cent among the majority of people who require treatment for high triglyceride
levels, suggests a study.
Reading over the new advisory, he said that "triglycerides
are now becoming the new 'bad cholesterol.'
Global Medium-chain Triglycerides
market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
They reported in the January issue of JAMA that reducing triglycerides
can lower CHD risk as much as reducing cholesterol, but they suggest that the real story isn't as simple as looking at just cholesterol or just triglycerides